Search Results - "Speakman, M.J."

Antibiotic prophylaxis is not necessary before local anaesthetic transperineal prostate biopsies - an institution’s experience of 443 consecutive cases by John, J.B., Maccormick, A., Macdonagh, R., Vennam, R., Speakman, M.J., Burns-Cox, N.

Get full text

A systematic review of patients’ values, preferences and expectations for the diagnosis and treatment of male Lower Urinary Tract Symptoms (LUTS) by Malde, S., Umbach, R., Wheeler, J.R., Lytvyn, L., Cornu, J-N., Gacci, M., Gratzke, C., Herrmann, T.R.W., Mamoulakis, C., Rieken, M., Speakman, M.J., Gravas, S., Drake, M.J., Guyatt, G.H., Tikkinen, K.A.O.

Get full text

Bladder outflow obstruction--a cause of denervation supersensitivity by Speakman, M J, Brading, A F, Gilpin, C J, Dixon, J S, Gilpin, S A, Gosling, J A

“…Eighteen Landrace pigs and 12 Göttingen mini-pigs were evaluated in a study of experimental bladder outflow obstruction. Twenty-two of the animals underwent…”
Get more information

1076 Two year results of the BPH6 trial: A multi-center, prospective, randomized study of the prostatic urethral lift (PUL) vs transurethral resection of the prostate (TURP) by Gratzke, C, Barber, N.J, Speakman, M.J, Berges, R, Wetterauer, U, Greene, D, Sievert, K-D, Chapple, C.R, Montorsi, F, Patterson, J.M, Fahrenkrug, L, Schoenthaler, M, Sønksen, J

Get full text

The use of generic measures of health‐related quality of life in the assessment of outcome from transurethral resection of the prostate by MacDonagh, R.P., Cliff, A.M., Speakman, M.J., O'Boyle, P.J., Ewings, P., Gudex, C.

“…Objectives To investigate the performance of the EuroQol (EQ) quality‐of‐life measure and the Nottingham Health Profile (NHP) in assessing the outcome of…”
Get full text

Guideline for the primary care management of male lower urinary tract symptoms by Speakman, M.J., Kirby, R.S., Joyce, A., Abrams, P., Pocock, R.

“…As my Comment in the first section of the journal suggested, the MTOPS results have offered the possibility to general practitioners of reducing the risk of…”
Get full text

Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction by Höfner, K, Claes, H, De Reijke, T M, Folkestad, B, Speakman, M J

“…To evaluate the effect of tamsulosin, 0.4 mg once daily, on sexual function in comparison with placebo and alfuzosin, 2.5 mg three times daily, in patients…”
Get more information

Management of urinary retention in patients with benign prostatic obstruction: A systematic review and meta-analysis by Karavitakis, M., Kyriazis, I., Omar, M.I., Gravas, S., Cornu, J-N., Drake, M.J., Gacci, M., Gratzke, C., Herrmann, T.R.W., Madersbacher, S., Rieken, M., Speakman, M.J., Tikkinen, K.A., Yuan, Y., Mamoulakis, C.

Get full text

PT166 - Management of urinary retention in patients with benign prostatic obstruction: A systematic review and meta-analysis by Karavitakis, M., Kyriazis, I., Omar, M.I., Gravas, S., Cornu, J-N., Drake, M.J., Gacci, M., Gratzke, C., Herrmann, T.R.W., Madersbacher, S., Rieken, M., Speakman, M.J., Tikkinen, K.A., Yuan, Y., Mamoulakis, C.

Get full text

Tamsulosin is effective in patients with lower urinary tract symptoms/benign prostatic hyperplasia, irrespective of prostate size by Speakman, M.J., Snijder, J.R., Anthonijs, G.L., Doyle, C.A., Carter, A.

Get full text

Baseline prostate specific antigen does not affect the efficacy of tamsulosin in patients with lower urinary tract symptoms/benign prostatic hyperplasia by Speakman, M.J., Snijder, J.R., Anthonijs, G.L., Doyle, C.A.

Get full text

Multiple use of fibres in the visual laser ablation of the prostate by Gilbert, H W, O'Boyle, P J, McLoughlin, J, Speakman, M J

“…To investigate the possibility of re-using laser fibres for the visual laser ablation of the prostate (VLAP). Thirty-four patients, each with a mean maximum…”
Get more information